Allergan Breast Implant Lawsuit in Oklahoma

Time limits apply in Oklahoma. Find out if you still qualify.

Free Case Review

Start Your Free Review

Answer 2-3 quick questions to review your potential case.

Researched By
People's Justice Research Team

Verified against court records, regulatory records, and peer-reviewed research.

Last reviewed: June 11, 2026How we research

Last reviewed against primary sources: June 11, 2026

Statute of Limitations

Oklahoma: 2 years from discovery (12 O.S. § 95)

2 years from BIA-ALCL diagnosis or discovery of BIOCELL injury connection

Filing Venue

Where to File in Oklahoma

Oklahoma has a 2-year personal injury statute under 12 O.S. § 95 with the discovery rule. Oklahoma plaintiffs file in MDL 2921 in the District of New Jersey. Oklahoma City and Tulsa plastic surgery markets placed Allergan BIOCELL products during the 2005–2019 period. BIA-ALCL diagnoses in Oklahoma from 2024 onward are within the 2-year limitations period. Claimants with earlier diagnoses should consult an attorney immediately regarding discovery rule and tolling arguments.

Oklahoma Data

Exposure in Oklahoma

Source: FDA MAUDE Database

Source: FDA Adverse Event Reporting System